According to Analysts, the Core Problem of the Pfizer Acquisition

Multiple Choice

According to analysts, the core problem of the Pfizer acquisition of Wyeth was that

A) Wyeth had been investing heavily in biotechnology and vaccines for about three decades.
B) Pfizer wanted to gain access to new products that might flow from Wyeth's biotechnology-oriented R&D investments.
C) Lipitor was a failure for Pfizer and Wyeth did not have the potential to contribute a top-selling drug.
D) it did not deal with the fact that Pfizer was struggling to develop new products in-house.